These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2826282)

  • 21. New frontiers in biomarkers for hepatocellular carcinoma.
    Giannelli G; Antonaci S
    Dig Liver Dis; 2006 Nov; 38(11):854-9. PubMed ID: 16782417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatoma-related gamma-glutamyl transferase in laboratory or clinical diagnosis of hepatocellular carcinoma.
    Yao DF; Dong ZZ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):9-11. PubMed ID: 17287158
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on protein phosphatase 1/2A in liver cancer tissues: preliminary report].
    Sakon M; Murata K; Okuyama M; Yukawa M; Kambayashi J; Monden M; Mori T
    Nihon Geka Gakkai Zasshi; 1993 Mar; 94(3):318. PubMed ID: 8391107
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening for hepatocellular carcinoma.
    Haydon GH; Hayes PC
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):856-60. PubMed ID: 8889450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
    Tateishi R; Shiina S; Yoshida H; Teratani T; Obi S; Yamashiki N; Yoshida H; Akamatsu M; Kawabe T; Omata M
    Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 28. Performance characteristics of the LiBASys des-gamma-carboxy prothrombin assay.
    Owen WE; Roberts RF; Roberts WL
    Clin Chim Acta; 2008 Mar; 389(1-2):183-5. PubMed ID: 18164263
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of pedunculated hepatoma suspected of adrenal tumor].
    Hanai T; Miyatake R; Hashimoto K; Kato Y; Iguchi M
    Hinyokika Kiyo; 1999 Jun; 45(6):411-3. PubMed ID: 10442283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumor markers for hepatocellular carcinoma].
    Fujiyama S; Tanaka M; Maeda S; Ashihara H; Hirata R
    Gan To Kagaku Ryoho; 2001 May; 28(5):723-32. PubMed ID: 11383225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of retinol-binding protein and prealbumin assay as a tumor marker].
    Hachimura K; Sekiya K
    Nihon Rinsho; 1990 Feb; 48 Suppl():1042-4. PubMed ID: 2162411
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatocellular carcinoma development in cirrhosis.
    Okuda H
    Best Pract Res Clin Gastroenterol; 2007; 21(1):161-73. PubMed ID: 17223503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The new generation of hepatocellular markers.
    Mount S
    Cancer Cytopathol; 2012 Aug; 120(4):217-9. PubMed ID: 22760992
    [No Abstract]   [Full Text] [Related]  

  • 35. [Expression and clinical significance of telomerase hTRT in primary hepatocellular carcinoma].
    Zhou YJ; Zhang XF; Lu HS; Huang CM; Yang FD; Wang C
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):500. PubMed ID: 15329219
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent advances in tumor markers of human hepatocellular carcinoma.
    Yoon SK
    Intervirology; 2008; 51 Suppl 1():34-41. PubMed ID: 18544946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma.
    Tsutsumi M; Sakamuro D; Takada A; Zang SC; Furukawa T; Taniguchi N
    Hepatology; 1996 May; 23(5):1093-7. PubMed ID: 8621139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
    Torzilli G; Makuuchi M; Ferrero A; Takayama T; Hui AM; Abe H; Inoue K; Nakahara K
    Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma.
    Jakubovic BD; Jothy S
    Exp Mol Pathol; 2007 Apr; 82(2):184-9. PubMed ID: 17258707
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
    Pitman MB; Triratanachat S; Young RH; Oliva E
    Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.